Aim: This review aims to reassess the role of saturated fatty acids (SFAs) in the diet in light of recent evidence which shows that consumption of SFAs is probably safer than previously thought.
INTRODUCTION
Fats act as precursors of many essential compounds required by the body. In common term, the oils used for cooking (liquid) and solid fats (butter, ghee, etc.) are together referred to as fats. These add taste, texture, flavor to food and make it palatable. Fats serve as rich sources of energy (1 fat = 9 Kcals) and also provide a supply of essential fatty acids (linoleic n-6 and alpha-linolenic n-3). Fatty acids (FAs) are the building blocks all dietary fats. They are chiefly of two types; saturated fatty acids (SFAs) and unsaturated {monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs). Tocopherols, tocotrienols, sterols, etc. are minor components found in dietary fats. They add natural flavor to fats/oils. They also act as antioxidants and prevent rancidity. They have been reported to lower blood cholesterol level. The process of refining of oils alters the content of minor elements. Saturated fatty acids are an integral component of dietary fat. It has long been leveled to have a deleterious effect on health if consumed in excess. Several intervention studies, from the past, which had concluded in favor of restricting dietary SFA had its fallacies. The association between SFA and non-communicable diseases like diabetes, hypertension and cardiovascular diseases has been studied and debated for the past few decades. The belief about the adverse effects of SFA has been challenged by some recent studies and meta-analysis which depicted that consumption of carbohydrates rather than SFA is possibly the main culprit for the causation of noncommunicable diseases. This has raised the need for reassessment of dietary guidelines for saturated fat consumption.
Important Physiological Roles of Fat
Fats are an important source of energy. However, they also play many other physiological roles as depicted in Table 1. Table 2 enumerates various common dietary sources of FA.
TYPES OF SFAs AS PER CARBON CHAIN LENGTH
SFAs can be classified as short-chain (SC), mediumchain (MC) and long-chain (LC). A combination of these, along with monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) are found in dairy fat.
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Saturated Fatty Acids in Commonly Consumed Foods and Oils
Indian food is cooked mainly with a fat medium like mustard oil, coconut oil, ghee, butter or vanaspati. Table 3 enumerates the saturated fatty acids found in commonly consumed foods and oils.
Biomarkers for SFA
There are certain biomarkers in the blood by which we can predict the presence or absence of fatty acids. Pentadecanoic (15:0) and margaric (17:0) acid, are not synthesized in humans. They are valid biomarkers for dairy or lamb, beef, venison, and fatty fish intake.
1,2 The dietary palmitic acid (16:0) intake can be assessed by measuring the ratio of 16:1 to 16:0.
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SFAs, Trans-Fats (TFA) and Adverse Health Outcomes
SFA resembles TFAs in molecular geometry. Transfats are found in partially hydrogenated vegetable fats, junk foods, ruminant milk, and meats. They are attributed to adverse metabolic effects and have been associated with obesity, insulin resistance, endothelial inflammation, and atherosclerosis. 
• Effect on circulating lipid metabolism (Flowchart 2):
SFAs act through stearoyl-CoA desaturase-1 (SCD1) by increasing the enzyme's activity which, in turn, decreases fat accumulation in liver but increases plasma VLDLs. The atherosclerotic effect is through the formation of foam cells via synthesis of cholesteryl oleate from SCD1. there is increased cell death. SFAs can cause decreased production of adiponectin and also decreased phosphorylation of insulin receptors and its substrate-1, which in turn promote insulin resistance.
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• Effects of SFAs on cardiometabolic health are enumerated in Table 4 .
• Various beneficial effects of SFAs: Saturated fatty acids
are also reported to have many beneficial effects including protection against intestinal inflammation and promotion of weight loss. The beneficial effects are outlined in Table 5 .
SFA Consumption and the Indian Diet
The cooking media used in Indian diet has a wide range of visible and invisible fat. Table 6 describes various constituents of common cooking media, calorie content and recommended daily allowance (RDA).
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ICMR Recommendations (2011) on Fat Consumption
Indian Council for medical research dietary guidelines (2nd edition 2011) recommended that saturated fats should be limited to <10% (5-6% for those who would benefit from lowering of LDL cholesterol), and trans fats to <1% of energy or as low as possible, primarily to reduce risk of ischemic heart disease and stroke. 30 Calories from various Fatty Acids should be limited to SFA 8-10%, PUFA 8-10%, MUFA 8-10%. 30 The diet should contain more than one type of cooking oil to provide a variety of SFAs, PUFA, and MUFA (Table 7) . Regular consumption of oils and foods rich in alpha-linolenic (n-3) is to be ensured. Fish provides preformed long-chain n-3 PUFA. Nuts and legumes contain a good proportion of alpha-linolenic (n-3) acid, protein, fiber, vitamins, and minerals. A part of visible fat intake can be substituted by nuts and legumes. Certain other useful substances are found in plant oils such as sterols, tocopherols (vitamin E), lignans (sesame oil), oryzanol (rice bran oil), carotenoids. These are helpful in reducing cholesterol and also act as anti-oxidant. Hydrogenation of unsaturated fatty acids converts them to SFA, and the isomers are called trans-fat. Vanaspati is hydrogenated fat. It is used as a substitute for other cooking oils, ghee or butter. It keeps the foods prepared by it fresh for a longer time because of resistance to oxidation. Consumption of vanaspati also increases the intake of trans fatty acids which increases the risk of heart disease. The probable safe limit of consumption is less than 1% of total energy intake.
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VARIOUS STUDIES ON SFAs
Researchers have conducted various studies in the past to study the role of SFAs on health; however, there is no consensus on incriminating SFAs for ill health. Some studies have shown adverse effects of SFAs on health whereas other studies have failed to do so (Table 8) .
In a recent systematic review and meta-analysis of observational studies Russell J de Souza et al. studied the associations of communicable diseases outcome and all-cause mortality with intake of SFA and trans fat through both online and manual literature search and analysis of evidence-based medicine reviews (EBMR), Embase, Medline, Cochrane Central Registry of Controlled Trials and CINAHL till 1 May 2015. 32 With some methodological and heterogeneous limitations their analysis suggested that there is no association of SFA consumption with noncommunicable diseases like coronary heart disease, cerebrovascular disease, hypertension, type 2 diabetes, and all-cause mortality. However, consumption of trans fats, especially the industrially derived ones is associated with the adverse outcomes.
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CONCLUSION AND CLINICAL SIGNIFICANCE
Saturated fatty acids have been marked for decades to have deleterious effects on health and to be a risk factor for non-JOMA communicable diseases. This inference was based on the outcome of several prospective interventional trials which were either short duration studies or had many methodological or heterogeneous bias and limitations. None of the trials compared the effect of polyunsaturated fat on cardiovascular disease (CVD) and/or coronary heart disease (CHD) if replaced in place of saturated fat. Therefore, it is impossible to predict the solo effect of saturated fats on CVD/CHD. Recent advanced statistical techniques, large scale meta-analysis and interventional trials on specific SFAs on disease outcome have been changing the concept and understanding over the last few years. It has well been understood that replacing carbohydrates for SFAs has been associated with more adverse outcome. Recent systematic reviews and meta-analyses have disproved the older concept about SFAs. Therefore, consumption of SFAs is probably safe. The intake of industrialized fats, trans fats, and red meat should be limited. However, before coming to a definite conclusion and changing dietary recommendations, the authors suggest that long term, large populationbased prospective interventional cohort studies should be contemplated to study the possible effect of each different saturated fat on CHD/CVD with CVD as the endpoint and effect of dietary control of SFAs with plasma cholesterol level as the endpoint.
